Rubric Capital Management LP Theravance Biopharma, Inc. Transaction History

Rubric Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$8.39 - $10.22 $2.99 Million - $3.64 Million	356,100 New	356,100 $3.61 Million
Q4 2020 Feb 16, 2021	SELL	$14.89 - $20.16 $8.2 Million - $11.1 Million	-550,747 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$14.79 - $22.49 $5.85 Million - $8.9 Million	-395,710 Reduced 41.81%	550,747 $8.14 Million
Q2 2020 Aug 10, 2020	BUY	$20.64 - $30.69 $1.5 Million - $2.24 Million	72,880 Added 8.34%	946,457 $19.9 Million
Q1 2020 May 14, 2020	BUY	$17.84 - $31.21 $12.5 Million - $21.9 Million	700,177 Added 403.79%	873,577 $20.2 Million
Q4 2019 Feb 14, 2020	BUY	$16.12 - $25.89 $2.8 Million - $4.49 Million	173,400 New	173,400 $4.49 Million

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rubric Capital Management LP with notifications on news.